July 23, 2015

A new coalition has formed to ensure safe access to over-the-counter pain relief remedies. The Protecting Access to Pain Relief Coalition officially launched on June 22 to help ensure that American consumers continue to have access to, and choice of, safe and effective pain relief, including acetaminophen.

June 12, 2015

McNeil Consumer Healthcare, the makers of Tylenol, have launched the new #HowWeFamily effort.

May 27, 2015

Consumers in the Western United States don't plan on purchasing as many allergy medicines, a Field Agent survey found. 

March 13, 2015

An Alliance for Aging Research survey found that consumers want to maintain nonprescription access to acetaminophen. 

February 3, 2015

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

January 26, 2015

Purdue Pharma on Monday announced the launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII. According to the company, the once-daily drug is the first and only hydocodone product to be recognized by the Food and Drug Administration as having properties that deter misuse and abuse via chewing, snorting and injection.

January 14, 2015

The University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use. 

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

October 28, 2014

The Acetaminophen Awareness Coalition on Tuesday kicked off its annual “Double Check; Don’t Double Up” campaign.

October 15, 2014

The resurgence of iconic pain relief brands Tylenol and Excedrin continue to contribute to the slight growth across internal analgesic tablets. It’s a $3.2 billion book of business across U.S. multi-outlets, according to IRI, that is up slightly by 0.8% for the 52 weeks ended Aug. 10. 

October 15, 2014

According to a recent survey conducted by Mom Central in partnership with the makers of Tylenol, 52% of moms agree that a baby’s first fever is the most challenging motherhood moment, and 82% report they are most likely to consult their pediatrician to navigate such milestones. 

October 9, 2014

The Food and Drug Administration earlier this month issued draft guidance with several recommendations for manufacturers of acetaminophen products. 

October 8, 2014

Teva Pharmaceutical Industries on Wednesday announced the initiation of a rolling new drug application submission for hydrocodone bitartrate extended-release tablets.

September 15, 2014

Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.

September 5, 2014

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

September 4, 2014

Kline Group reported positive signs of 2013 growth across the over-the-counter sector in its recently published Nonprescription Drugs USA study, according to a blog posted Monday

August 25, 2014

Pharmaceutical company Iroko announced today that a new version its anti-inflammatory drug Zorvolex had been approved by the Food and Drug Administration.

August 20, 2014

The entire external analgesic category is up 6.7%, reaching a base of $486.9 million across total U.S. multi-outlets for the 52 weeks ended June 15, according to IRI data. And Salonpas, with a 10.9% dollar share, is helping to drive that growth with positive sales gains of 28.7% to $52.9 million.

August 20, 2014

GM Pharmaceuticals recently launched 8-oz. bottles of its liquid pain reliever, VanaPain, which includes 16 servings of its daytime pain reliever and eight servings of its nighttime pain reliever.

August 12, 2014

According to a survey conducted by Mom Central in partnership with McNeil Consumer Healthcare, many moms feel ill-equipped to manage the discomfort that comes along with many childhood "firsts." 

June 26, 2014

The Acetaminophen Awareness Coalition on Thursday released “Acetaminophen: How It’s Used, Preventing Overdose and What We Can Do to Promote Safe Use,” a report and educational resource to drive safe and appropriate use of one of the United States’ most common drug ingredients.

June 17, 2014

Lannett Co. received approval from the Food and Drug Administration for codeine sulfate tablets USP, a schedule II controlled substance, in 15 mg, 30 mg and 60 mg dosage strengths.

June 10, 2014

McNeil Consumer Healthcare on Monday announced the launch of Stories of Strength, a program that encourages people to honor someone who has been a source of strength in their lives.

May 29, 2014

Depomed on Wednesday announced that the Food and Drug Administration has accepted for filing a new drug application from Mallinckrodt for MNK-155.